BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32559452)

  • 1. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
    Afra TP; T MR; Bishnoi A; Hafi NB
    Lancet Infect Dis; 2020 Oct; 20(10):1120-1121. PubMed ID: 32559452
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxychloroquine prophylaxis for high-risk COVID-19 contacts in India: a prudent approach.
    Tilangi P; Desai D; Khan A; Soneja M
    Lancet Infect Dis; 2020 Oct; 20(10):1119-1120. PubMed ID: 32450054
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    de Miranda Santos IKF; Costa CHN
    Front Immunol; 2020; 11():1739. PubMed ID: 32849619
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine prophylaxis for SARS-CoV-2 infection among healthcare workers.
    R Karim HM; Ahmed G
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):119-120. PubMed ID: 32773410
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2.
    Neves FS
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):124-126. PubMed ID: 32801224
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen.
    Pareek A; Bhandari S; Mehta RT
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):130-132. PubMed ID: 32811798
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxychloroquine for chemoprophylaxis in COVID-19: A case of motivated perception?
    Manjunath BG; Tyagi D; Chaudhry D; Singh PK
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):116-118. PubMed ID: 32773415
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine prophylaxis for COVID-19 contacts in India.
    Rathi S; Ish P; Kalantri A; Kalantri S
    Lancet Infect Dis; 2020 Oct; 20(10):1118-1119. PubMed ID: 32311324
    [No Abstract]   [Full Text] [Related]  

  • 9. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Avidan MS; Dehbi HM; Delany-Moretlwe S
    N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
    Frigerio M
    Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
    [No Abstract]   [Full Text] [Related]  

  • 13. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
    Schluger NW
    Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
    Okafor EC; Pastick KA; Rajasingham R
    N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Tekwani BL
    N Engl J Med; 2020 Sep; 383(11):1088-1089. PubMed ID: 32668108
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Khan MS; Butler J
    N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic].
    Bozzo R; Ibelli F; Scublinsky D
    Medicina (B Aires); 2020; 80 Suppl 3():89-90. PubMed ID: 32658855
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence of Protective Effect of Hydroxychloroquine on COVID-19.
    Joob B; Wiwanitkit V
    J Rheumatol; 2020 Oct; 47(10):1587. PubMed ID: 32451353
    [No Abstract]   [Full Text] [Related]  

  • 19. The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.
    DeJong C; Wachter RM
    JAMA Intern Med; 2020 Aug; 180(8):1118-1119. PubMed ID: 32347894
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiac adverse effects of hydroxychloroquine and the need for tests].
    Zaidel EJ; Wyss Quintana FS; Sosa Liprandi Á; Mendoza I; Márquez MF; Nuñez E; Barbosa M; Baranchuk A
    Medicina (B Aires); 2020; 80 Suppl 3():91-92. PubMed ID: 32658856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.